S2k guideline basal cell carcinoma of the skin (update 2023)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024-12 · 22 (12) · 1697-1714
DOI: 10.1111/ddg.15566 ↗Kurz gefasst
Leitlinie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 25.11.2024. Verfasst von Berenice M Lang und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mainz University Medical Center, Mainz, Germany. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Basal cell carcinoma is the most common malignant tumor in the fair‐skinned population and its incidence continues to rise. An update of the S2k guideline with the participation of all specialist societies familiar with the clinical picture and previous literature research is of great importance for the quality of care for affected patients. In addition to epidemiology, diagnostics and histology are discussed. After risk stratification, therapy is divided into topical, systemic and radiation therapy. Surgical removal remains the treatment of first choice in most cases. The approval of anti‐PD1 inhibitors for locally advanced and metastatic tumors has opened up a new option in second‐line therapy (after hedgehog inhibitors).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Mainz University Medical Center, Mainz, Germany.
- Department of Radiation Oncology, University Hospital Zürich, Zürich, Switzerland.
- Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
- Dermatology and Teaching Office, Konstanz, Germany.
- CentroDerm, Wuppertal, Germany.
- Faculty of Health, University of Witten-Herdecke, Witten, Germany.
ORCID-Profile: Berenice M Lang, Christoph Löser, Julia Welzel, Stephan Grabbe
Zitieren
APA
Lang, B. M., Balermpas, P., Bauer, A., Blum, A., Dirschka, T., Follmann, M., Frank, J., Frerich, B., Fritz, K., Hauschild, A., Heindl, L. M., Howaldt, H. P., Ihrler, S., Kakkassery, V., Klumpp, B., Krause-Bergmann, A., Löser, C., Meissner, M., Sachse, M. M., …, & Grabbe, S. (2024). S2k guideline basal cell carcinoma of the skin (update 2023). JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(12), 1697-1714. https://doi.org/10.1111/ddg.15566
Vancouver
Lang BM, Balermpas P, Bauer A, Blum A, Dirschka T, Follmann M, et al. S2k guideline basal cell carcinoma of the skin (update 2023). JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(12):1697-1714. doi:10.1111/ddg.15566
BibTeX
@article{Lang2024,
author = {Lang, Berenice M and Balermpas, Panagiotis and Bauer, Andrea and Blum, Andreas and Dirschka, Thomas and Follmann, Markus and Frank, Jorge and Frerich, Bernhard and Fritz, Klaus and Hauschild, Axel and Heindl, Ludwig M and Howaldt, Hans-Peter and Ihrler, Stephan and Kakkassery, Vinodh and Klumpp, Bernhard and Krause-Bergmann, Albrecht and Löser, Christoph and Meissner, Markus and Sachse, Michael M and Schlaak, Max and Schön, Michael P and Tischendorf, Lutz and Tronnier, Michael and Vordermark, Dirk and Welzel, Julia and Weichenthal, Michael and Wiegand, Susanne and Kaufmann, Roland and Grabbe, Stephan},
title = {S2k guideline basal cell carcinoma of the skin (update 2023)},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
volume = {22},
number = {12},
pages = {1697--1714},
doi = {10.1111/ddg.15566}
}
EUVIMED